About Cassava Sciences (SAVA)
Cassava Sciences, Inc. is a clinical-stage biotechnology company. The Company is focused on developing the drug for the treatment of neurodegenerative diseases, such as Alzheimers disease. The Company’s products include Simufilam and SavaDx. Its lead... Read more
- USD1.82
- USD1.87
- USD1.78
- USD42.20
- 43.90%
- --
- 2.20k
- 863.43k
- 86M
- 1.15
- -91.60%
Stock News
1 hour ago
Munich Re, Hannover Re each report big losses from LA wildfires
MarketWatch
5 hours ago
Industrial Metals Breathe A Sigh Of Relief After China-U.S. Trade Truce
SeekingAlpha
5 hours ago
The Ripple Effect: Tariffs And Their Implications
SeekingAlpha
5 hours ago
Central Banks Are Treading Carefully
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
